Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439251/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439251/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease. Accessed January 17, 2025.
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439251/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
Combined Corticosteroid and Long‐acting Beta2‐agonist in One Inhaler Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439251/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
ID - 439251
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439251/all/Combined_corticosteroid_and_long‐acting_beta2‐agonist_in_one_inhaler_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -